Combination therapy response biomarkers of colorectal cancer
Posted in the Colon Cancer Forum
#1 Feb 21, 2012
According to this recent US patent application, high pretreatment plasma YKL-40 and serum YKL-40 levels were prognostic biomarkers of short overall survival in two independent studies of patients with metastatic colorectal cancer treated with third-line cetuximab in combination with irinotecan. Details: http://www.sciclips.com/sciclips/biomarker-ne...
Add your comments below
|can viagra make you go deaf?||Apr '16||Wyatt||1|
|viagra's hidden uses: diet pill, cancer fighter?||Mar '16||Howard||1|
|Testing, knowledge key to detecting colon cancer||Mar '16||huey goins||2|
|WGRZ News - Colon Cancer: One Man's Fight (Mar '08)||Jan '16||chris||15|
|Namber Of Plyps||Dec '15||Amy||2|
|Colon' back passage conditions including cancer' (Sep '15)||Sep '15||langham research ...||1|
|The 10 commandments of cancer prevention (May '09)||Sep '15||Stinky Pete||28|
Find what you want!
Search Colon Cancer Forum Now
Copyright © 2016 Topix LLC